This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated FST Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-FST WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~38 kDa | |
| Observed band | ~40 kDa | |
| Gel | 10–12% | |
| Positive control | Adipose tissue+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
| PTM | Glycosylated + Cleaved | |
| Caveat | Glycosylation increases size | |
| Regulation | Myogenesis | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for FST — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | mouse kidney , Lane 2: human MCF-7 . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-Follistatin antigen affinity purified polyclonal antibody (Catalog # A00972-1) at 0.5 ug/mL overnight at 4 then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:10000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for Follistatin at approximately 40KD. The expected band size for Follistatin is at 38KD |
| Gel % | 10–12% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:10000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 40 kDa |
FST has a 38 kDa predicted backbone but runs at approximately 40 kDa due to N-glycosylation at Asn124 and Asn288 following signal peptide cleavage.
| Single band at ~40 kDa | Mature, signal-peptide-cleaved follistatin carrying N-glycans at Asn124 and Asn288, running above its 38 kDa predicted mass |
| Diffuse or slightly smeared band around 38-42 kDa | Heterogeneous glycoform occupancy across the two N-linked glycosylation sites |
| Faint band just below the mature ~40 kDa band | Residual unglycosylated or signal-peptide-uncleaved precursor form |
| Two closely spaced bands | Co-expression of the two annotated splice isoforms (isoform 1 and isoform 2) |
| Little or no band in whole-cell lysate | Follistatin is actively secreted, so intracellular pools can be minimal |
| Predicted mass (UniProt) | 38 kDa unmodified backbone sets the baseline expectation before processing and modification |
| Signal peptide cleavage (residues 1-29) | Removal of the N-terminal signal peptide produces the mature secreted form, smaller than the unprocessed precursor |
| N-glycosylation at Asn124 and Asn288 | Two N-linked glycans add mass, shifting the mature band up toward the ~40 kDa observed size and potentially broadening it |
| Alternative splicing (isoforms 1 and 2) | The two named isoforms can migrate at slightly different apparent sizes, producing an extra band relative to the canonical form |
| Secreted subcellular localization | Signal is often stronger in conditioned media or serum/plasma than in whole-cell lysate |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Follistatin is a secreted protein with limited intracellular retention | Test conditioned media, serum, or plasma alongside or instead of whole-cell lysate |
| Band higher than expected | N-glycosylation at Asn124 and Asn288 adds mass above the 38 kDa predicted backbone | Treat the ~40 kDa empirical band as the expected size rather than the unmodified predicted mass, and confirm with PNGase F treatment as a lower-bound control |
| Broad smear instead of sharp band | Heterogeneous glycosylation across the two N-linked sites produces a range of glycoforms | Run a longer resolving gel or deglycosylate with PNGase F to collapse the smear into a single sharp band |
| Multiple bands | The two annotated splice isoforms may be co-expressed in the same sample | Verify isoform identity with mass comparison or an isoform-specific antibody epitope |
| Weak or no signal | Low secretion output or dilution of the secreted antigen in conditioned media | Concentrate conditioned media or increase sample loading and exposure time before repeating |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | lymphoid tissue | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | lymphoid tissue | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for FST, answered from its protein features.
BosterBio's FST antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-Follistatin antibody is a top-performing, extensively cited reagent, rigorously validated by Western blot and cross-checked against negative tissue and complementary detection methods to ensure specificity and reliable results for your FST studies.
Which to pick: Only one Boster FST antibody is catalogued here, A00972-1, which includes an actual Western blot validation image—making it the clear choice for reliable, image-confirmed detection of Follistatin in your samples.